Physician profile
Eric Asbe
NPI 1629420989
$4,296.96
in general payments reported to CMS, 2019-2025
9 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.65 · 2024: $4,063 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,475 · Food and Beverage: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,475.47 |
| Food and Beverage | $290.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,008.22 | 2024 | |
| Verona Pharma, INC. | $121.13 | 2025 | Ohtuvayre |
| Insmed, INC. | $42.50 | 2025 | Brinsupri |
| Abiomed | $32.40 | 2024 | Impella |
| Grifols USA, LLC | $23.83 | 2025 | Prolastin-C Liquid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.89 | 2024 | Xifaxan |
| Novo Nordisk INC | $18.78 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.34 | 2025 | Jascayd |
| Janssen Pharmaceuticals, INC | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Asbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.